Caber By Ultima Pharmaceuticals
"Caber" is a colloquial abbreviation for Cabergoline, which is a medication used for various medical purposes. Cabergoline is primarily known for its role in the treatment of certain medical conditions, including hyperprolactinemia, which is a condition characterized by elevated levels of the hormone prolactin in the bloodstream. Cabergoline works by reducing prolactin levels in the body.
Here are some common medical uses for Cabergoline:
- Hyperprolactinemia: Cabergoline is often prescribed to treat hyperprolactinemia, a condition where the pituitary gland produces an excessive amount of prolactin. High prolactin levels can lead to a range of symptoms, including irregular menstrual cycles, breast milk production in non-pregnant or non-nursing women, and sexual dysfunction. Cabergoline helps lower prolactin levels and alleviate these symptoms.
- Prolactinoma: Cabergoline is also used to manage pituitary tumors known as prolactinomas, which can lead to high prolactin levels and related symptoms. It can help reduce the size of these tumors and control prolactin levels.
- Parkinson's Disease: In some cases, Cabergoline is used to treat Parkinson's disease as it works as a dopamine agonist, helping to improve motor symptoms.
- Restless Legs Syndrome: Cabergoline may be prescribed for individuals with severe Restless Legs Syndrome (RLS) that doesn't respond well to other treatments.
- Off-Label Uses: Cabergoline may also have off-label uses in various medical conditions, but these uses would be determined by a healthcare provider based on an individual's specific medical needs.
For conditions like hyperprolactinemia or prolactinoma, the typical starting dose of Cabergoline for adults is often low, such as 0.25 mg (milligrams) per week, divided into multiple smaller doses. This dose may be gradually adjusted based on the response and the individual's tolerance, but it is essential to follow the healthcare provider's instructions.
For other uses of Cabergoline, such as in the treatment of Parkinson's disease or Restless Legs Syndrome, the dosing regimen and the starting dose can differ significantly from those for hyperprolactinemia or prolactinoma.